DE69428356D1 - Reinigung von plasmaproteinen - Google Patents

Reinigung von plasmaproteinen

Info

Publication number
DE69428356D1
DE69428356D1 DE69428356T DE69428356T DE69428356D1 DE 69428356 D1 DE69428356 D1 DE 69428356D1 DE 69428356 T DE69428356 T DE 69428356T DE 69428356 T DE69428356 T DE 69428356T DE 69428356 D1 DE69428356 D1 DE 69428356D1
Authority
DE
Germany
Prior art keywords
pct
aqueous phase
detergent
sec
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69428356T
Other languages
English (en)
Other versions
DE69428356T2 (de
Inventor
Sven Isaksson
Stefan Winge
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Octapharma AG
Original Assignee
Pharmacia AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia AB filed Critical Pharmacia AB
Application granted granted Critical
Publication of DE69428356D1 publication Critical patent/DE69428356D1/de
Publication of DE69428356T2 publication Critical patent/DE69428356T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/79Transferrins, e.g. lactoferrins, ovotransferrins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/30Extraction; Separation; Purification by precipitation
    • C07K1/303Extraction; Separation; Purification by precipitation by salting out
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76Albumins
    • C07K14/765Serum albumin, e.g. HSA
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/8107Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121Serpins
    • C07K14/8125Alpha-1-antitrypsin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Treatments Of Macromolecular Shaped Articles (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
DE69428356T 1993-05-07 1994-05-06 Reinigung von plasmaproteinen Expired - Lifetime DE69428356T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE19939301582A SE9301582D0 (sv) 1993-05-07 1993-05-07 Purification of plasma proteins
PCT/SE1994/000422 WO1994026287A1 (en) 1993-05-07 1994-05-06 Purification of plasma proteins

Publications (2)

Publication Number Publication Date
DE69428356D1 true DE69428356D1 (de) 2001-10-25
DE69428356T2 DE69428356T2 (de) 2002-04-25

Family

ID=20389869

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69428356T Expired - Lifetime DE69428356T2 (de) 1993-05-07 1994-05-06 Reinigung von plasmaproteinen

Country Status (15)

Country Link
US (1) US5817765A (de)
EP (1) EP0700300B1 (de)
JP (1) JP3771935B2 (de)
AT (1) ATE205719T1 (de)
AU (1) AU677332B2 (de)
CA (1) CA2161804C (de)
DE (1) DE69428356T2 (de)
DK (1) DK0700300T3 (de)
ES (1) ES2164702T3 (de)
FI (1) FI113779B (de)
NO (1) NO313084B1 (de)
NZ (1) NZ266234A (de)
PT (1) PT700300E (de)
SE (1) SE9301582D0 (de)
WO (1) WO1994026287A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9500724D0 (sv) 1994-06-23 1995-02-24 Pharmacia Ab Filtrering
ES2099678B1 (es) * 1995-11-03 1998-02-16 Grifols Grupo Sa Procedimiento para la inactivacion de virus en proteinas.
SE9902388D0 (sv) * 1999-06-23 1999-06-23 Pharmacia & Upjohn Ab Method for purification of proteins
US6518406B1 (en) 1999-06-23 2003-02-11 Octapharma Ag Method for purification of proteins
DE19932782A1 (de) * 1999-07-14 2001-01-18 Biotest Pharma Gmbh Verfahren zur chromatographischen Fraktionierung von Plasma oder Serum, so erhaltene Präparate und deren Verwendung
KR20020063597A (ko) * 1999-12-20 2002-08-03 미츠비시 웰파마 가부시키가이샤 다공성막으로 처리되어 바이러스가 제거된 혈장 단백질조성물 및 그 제조 방법
CA2534900A1 (en) * 2003-08-12 2005-02-17 Octapharma Ag Process for preparing an alpha-1-antitrypsin solution
CA2572327A1 (en) * 2004-06-29 2006-02-02 Reliance Life Sciences Pvt. Ltd. Process for the preparation of virus-safe biological fluids
AU2005229674B2 (en) * 2004-11-18 2010-11-04 Kedrion Melville Inc. Low concentration solvent/detergent process of immuneglobulin with pre-treatment
WO2010033913A1 (en) * 2008-09-22 2010-03-25 Icb International, Inc. Antibodies, analogs and uses thereof
US20100136584A1 (en) * 2008-09-22 2010-06-03 Icb International, Inc. Methods for using antibodies and analogs thereof
CA2742817A1 (en) 2008-11-20 2010-05-27 Biogen Idec Ma Inc. Arginine inactivation of viruses
CN102812118B (zh) * 2010-04-08 2016-01-20 恰根有限公司 分离和纯化核酸的方法
EP2395082A1 (de) 2010-06-14 2011-12-14 QIAGEN GmbH Extraktion von Nukleinsäuren aus in Wachs eingebetteten Proben
US8921062B2 (en) 2010-11-09 2014-12-30 Quest Diagnostics Investments Incorporated Diagnostic and prognostic assays based on circulating tyrosine kinase activity
US10112987B2 (en) 2012-01-09 2018-10-30 Icb International, Inc. Blood-brain barrier permeable peptide compositions comprising a vab domain of a camelid single domain heavy chain antibody against an amyloid-beta peptide
US10112988B2 (en) 2012-01-09 2018-10-30 Icb International, Inc. Methods of assessing amyloid-beta peptides in the central nervous system by blood-brain barrier permeable peptide compositions comprising a vab domain of a camelid single domain heavy chain antibody against an anti-amyloid-beta peptide
US9534029B2 (en) 2012-10-03 2017-01-03 Csl Behring Ag Method of purifying proteins
WO2014055552A1 (en) * 2012-10-03 2014-04-10 Csl Behring Llc A method of purifying proteins
US10836790B1 (en) * 2019-09-20 2020-11-17 Plasma Technologies, Llc Therapeutic protein compositions and methods
US10815270B1 (en) * 2019-09-20 2020-10-27 Plasma Technologies, Llc Compositions and methods for high efficiency protein precipitation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4540573A (en) * 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
US4764369A (en) * 1983-07-14 1988-08-16 New York Blood Center Inc. Undenatured virus-free biologically active protein derivatives
US4820805A (en) * 1983-07-14 1989-04-11 New York Blood Center, Inc. Undenatured virus-free trialkyl phosphate treated biologically active protein derivatives
US4684723A (en) * 1985-09-11 1987-08-04 Miles Laboratories, Inc. Method of separating proteins from aqueous solutions
US4789545A (en) * 1986-03-31 1988-12-06 New York Blood Center, Inc. Removal of lipid soluble process chemicals from biological materials by extraction with naturally occurring oils or synthetic substitutes thereof
ATE85221T1 (de) * 1988-11-05 1993-02-15 Octapharma Ag Verfahren zur herstellung eines hochreinen, nicht infektioesen antihaemophiliefaktors mittels chromatographie.
US5395923A (en) * 1993-02-23 1995-03-07 Haemacure-Biotech, Inc. Process for the obtention of a biological adhesive made of concentrated coagulation factors by "salting-out"

Also Published As

Publication number Publication date
CA2161804C (en) 2003-12-02
NO313084B1 (no) 2002-08-12
ES2164702T3 (es) 2002-03-01
AU677332B2 (en) 1997-04-17
JP3771935B2 (ja) 2006-05-10
CA2161804A1 (en) 1994-11-24
DE69428356T2 (de) 2002-04-25
SE9301582D0 (sv) 1993-05-07
JPH08509746A (ja) 1996-10-15
FI955306A (fi) 1995-11-06
NO954428L (no) 1995-11-06
ATE205719T1 (de) 2001-10-15
PT700300E (pt) 2002-03-28
NZ266234A (en) 1996-06-25
EP0700300B1 (de) 2001-09-19
FI113779B (fi) 2004-06-15
WO1994026287A1 (en) 1994-11-24
FI955306A0 (fi) 1995-11-06
NO954428D0 (no) 1995-11-06
DK0700300T3 (da) 2001-12-31
US5817765A (en) 1998-10-06
EP0700300A1 (de) 1996-03-13
AU6763494A (en) 1994-12-12

Similar Documents

Publication Publication Date Title
DE69428356D1 (de) Reinigung von plasmaproteinen
DK0707594T3 (da) Adskillelse af proteiner
ATE346088T1 (de) Kristallisierbare zusammensetzungen, die einen komplex von protease-domäne ns3 und ns4a aus dem hepatitis c virus enthalten, und damit bereitgestellte kristalle
NO964590L (no) Töyvaskemidler omfattende subtilisin BPN'-varianter
DK0775150T3 (da) Fremgangsmåde til reduktion eller fjernelse af endotoksiner
DE60135024D1 (de) Körperreinigungsmittel
DE69523161T2 (de) Salzlösung zur behandlung von kontaktlinsen
ATE171189T1 (de) Trennung von proteinen
PL322163A1 (en) Hydroxyethylaminosulphonamides of bis-amino acids as inhibitors of retroviral protease
NO911448D0 (no) Enzymstabiliserende blanding og rensevirkningsoekende vaskemiddelblandinger inneholdende stabilisert enzym.
DE59308628D1 (de) Verfahren zur Herstellung von Faktor VIII
DE3763601D1 (de) Verfahren zum isolieren und reinigen von haemin.
DK1329461T3 (da) Fremgangsmåde til fjernelse af humane serum-albumin-polymerer
DK0813591T3 (da) Pastaformigt rengøringsmiddel
DE69029471D1 (de) Wiedergewinnungsverfahren von mikrobiell erzeugtem chymosin
DE69811758D1 (de) Verwendung von Hyaluronsäure zur Herstellung einer wässrigen Lösung verwendbar als intra-artikulare Reinigungslösung
FI1343809T4 (fi) Menetelmä alfa-1 proteinaasinestäjän valmistamiseksi
ATE214618T1 (de) Desinfektion durch partikelgebundene und insolubilisierte detergentien
CA2271819A1 (en) Cleaning method for polyethylene terephthalate containers
ES2134920T3 (es) Composiciones acuosas de caracter fuertemente acido, estables, que contienen sales de persulfato.
NO994821L (no) Fremgangsmåte ved inaktivering av patogener, spesielt virus, i et biologisk materiale
ATE103606T1 (de) Verfahren zur herstellung von sulfinylpristinamycin iib.
DK1251940T3 (da) Fremgangsmåde til behandling af röggasrensningsprodukter

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: BIOVITRUM AB, STOCKHOLM, SE

8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: OCTAPHARMA AG, LACHEN, CH